Non-Alcoholic Steatohepatitis Biomarkers Market Size, Share, Trends, Industry Report & Forecast 2028

Non-Alcoholic Steatohepatitis Biomarkers Market

Non-Alcoholic Steatohepatitis Biomarkers Market By Biomarker Type (Serum Biomarkers, Biomarker Panels, Fibrosis Biomarkers, and Imaging Biomarkers), By End-Users (Hospitals, Diagnostic Centers, and Others), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 - 2028

Category: Healthcare Report Format : PDF Pages: 267 Report Code: ZMR-6113 Published Date: Aug-2022 Status : Published
Market Size in 2021 Market Forecast in 2028 CAGR (in %) Base Year
USD 1,218.5 Million USD 5,234.6 Million 27.5% 2021

Non-Alcoholic Steatohepatitis Biomarkers Market

Table Of Content

  • Chapter 1. Preface
    • 1.1 Report Description and Scope
    • 1.2 Research scope
    • 1.3 Research methodology
      • 1.3.1 Market Research Type
      • 1.3.2 Market research methodology
  • Chapter 2. Executive Summary
    • 2.1 Global Non-Alcoholic Steatohepatitis Biomarkers Market, (2022 - 2028) (USD Million)
    • 2.2 Global Non-Alcoholic Steatohepatitis Biomarkers Market : snapshot
  • Chapter 3. Global Non-Alcoholic Steatohepatitis Biomarkers Market - Industry Analysis
    • 3.1 Non-Alcoholic Steatohepatitis Biomarkers Market: Market Dynamics
    • 3.2 Market Drivers
      • 3.2.1 Increase in NAFLD and NASH prevalence is predicted to drive global market
    • 3.3 Market Restraints
      • 3.3.1. Lack of professionals and high infrastructure requirements is restraining the market growth
    • 3.4 Market Opportunities
    • 3.5 Market Challenges
    • 3.6 Porter’s Five Forces Analysis
    • 3.7 Market Attractiveness Analysis
      • 3.7.1 Market attractiveness analysis By Biomarker Type
      • 3.7.2 Market attractiveness analysis By End-User
  • Chapter 4. Global Non-Alcoholic Steatohepatitis Biomarkers Market- Competitive Landscape
    • 4.1 Company market share analysis
      • 4.1.1 Global Non-Alcoholic Steatohepatitis Biomarkers Market: company market share, 2021
    • 4.2 Strategic development
      • 4.2.1 Acquisitions & mergers
      • 4.2.2 New Product launches
      • 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4 Research and development and Regional expansion
    • 4.3 Price trend analysis
  • Chapter 5. Global Non-Alcoholic Steatohepatitis Biomarkers Market - Biomarker Type Analysis
    • 5.1 Global Non-Alcoholic Steatohepatitis Biomarkers Market overview: By Biomarker Type
      • 5.1.1 Global Non-Alcoholic Steatohepatitis Biomarkers Market share, By Biomarker Type, 2021 and 2028
    • 5.2 Serum Biomarkers
      • 5.2.1 Global Non-Alcoholic Steatohepatitis Biomarkers Market by Serum Biomarkers, 2022 - 2028 (USD Million)
    • 5.3 Biomarker Panels
      • 5.3.1 Global Non-Alcoholic Steatohepatitis Biomarkers Market by Biomarker Panels, 2022 - 2028 (USD Million)
    • 5.4 Fibrosis Biomarkers
      • 5.4.1 Global Non-Alcoholic Steatohepatitis Biomarkers Market by Fibrosis Biomarkers, 2022 - 2028 (USD Million)
    • 5.5 Imaging Biomarkers
      • 5.5.1 Global Non-Alcoholic Steatohepatitis Biomarkers Market by Imaging Biomarkers, 2022 - 2028 (USD Million)
    • 5.6 Others
      • 5.6.1 Global Non-Alcoholic Steatohepatitis Biomarkers Market by Others, 2022 - 2028 (USD Million)
  • Chapter 6. Global Non-Alcoholic Steatohepatitis Biomarkers Market - End-User Analysis
    • 6.1 Global Non-Alcoholic Steatohepatitis Biomarkers Market overview: By End-User
      • 6.1.1 Global Non-Alcoholic Steatohepatitis Biomarkers Market share, By End-User, 2021 and 2028
    • 6.2 Hospitals
      • 6.2.1 Global Non-Alcoholic Steatohepatitis Biomarkers Market by Hospitals, 2022 - 2028 (USD Million)
    • 6.3 Diagnostic Centers
      • 6.3.1 Global Non-Alcoholic Steatohepatitis Biomarkers Market by Diagnostic Centers, 2022 - 2028 (USD Million)
    • 6.4 Others
      • 6.4.1 Global Non-Alcoholic Steatohepatitis Biomarkers Market by Others, 2022 - 2028 (USD Million)
  • Chapter 7. Non-Alcoholic Steatohepatitis Biomarkers Market - Regional Analysis
    • 7.1 Global Non-Alcoholic Steatohepatitis Biomarkers Market Regional Overview
    • 7.2 Global Non-Alcoholic Steatohepatitis Biomarkers Market Share, by Region, 2021 & 2028 (USD Million)
    • 7.3. North America
      • 7.3.1 North America Non-Alcoholic Steatohepatitis Biomarkers Market, 2022 - 2028 (USD Million)
        • 7.3.1.1 North America Non-Alcoholic Steatohepatitis Biomarkers Market, by Country, 2022 - 2028 (USD Million)
    • 7.4 North America Non-Alcoholic Steatohepatitis Biomarkers Market, by Biomarker Type, 2022 - 2028
      • 7.4.1 North America Non-Alcoholic Steatohepatitis Biomarkers Market, by Biomarker Type, 2022 - 2028 (USD Million)
    • 7.5 North America Non-Alcoholic Steatohepatitis Biomarkers Market, by End-User, 2022 - 2028
      • 7.5.1 North America Non-Alcoholic Steatohepatitis Biomarkers Market, by End-User, 2022 - 2028 (USD Million)
    • 7.4. Europe
      • 7.4.2 Europe Non-Alcoholic Steatohepatitis Biomarkers Market, 2022 - 2028 (USD Million)
        • 7.4.2.1 Europe Non-Alcoholic Steatohepatitis Biomarkers Market, by Country, 2022 - 2028 (USD Million)
    • 7.4 Europe Non-Alcoholic Steatohepatitis Biomarkers Market, by Biomarker Type, 2022 - 2028
      • 7.4.1 Europe Non-Alcoholic Steatohepatitis Biomarkers Market, by Biomarker Type, 2022 - 2028 (USD Million)
    • 7.5 Europe Non-Alcoholic Steatohepatitis Biomarkers Market, by End-User, 2022 - 2028
      • 7.5.1 Europe Non-Alcoholic Steatohepatitis Biomarkers Market, by End-User, 2022 - 2028 (USD Million)
    • 7.5. Asia Pacific
      • 7.5.3 Asia Pacific Non-Alcoholic Steatohepatitis Biomarkers Market, 2022 - 2028 (USD Million)
        • 7.5.3.1 Asia Pacific Non-Alcoholic Steatohepatitis Biomarkers Market, by Country, 2022 - 2028 (USD Million)
    • 7.4 Asia Pacific Non-Alcoholic Steatohepatitis Biomarkers Market, by Biomarker Type, 2022 - 2028
      • 7.4.1 Asia Pacific Non-Alcoholic Steatohepatitis Biomarkers Market, by Biomarker Type, 2022 - 2028 (USD Million)
    • 7.5 Asia Pacific Non-Alcoholic Steatohepatitis Biomarkers Market, by End-User, 2022 - 2028
      • 7.5.1 Asia Pacific Non-Alcoholic Steatohepatitis Biomarkers Market, by End-User, 2022 - 2028 (USD Million)
    • 7.6. Latin America
      • 7.6.4 Latin America Non-Alcoholic Steatohepatitis Biomarkers Market, 2022 - 2028 (USD Million)
        • 7.6.4.1 Latin America Non-Alcoholic Steatohepatitis Biomarkers Market, by Country, 2022 - 2028 (USD Million)
    • 7.4 Latin America Non-Alcoholic Steatohepatitis Biomarkers Market, by Biomarker Type, 2022 - 2028
      • 7.4.1 Latin America Non-Alcoholic Steatohepatitis Biomarkers Market, by Biomarker Type, 2022 - 2028 (USD Million)
    • 7.5 Latin America Non-Alcoholic Steatohepatitis Biomarkers Market, by End-User, 2022 - 2028
      • 7.5.1 Latin America Non-Alcoholic Steatohepatitis Biomarkers Market, by End-User, 2022 - 2028 (USD Million)
    • 7.7. The Middle-East and Africa
      • 7.7.5 The Middle-East and Africa Non-Alcoholic Steatohepatitis Biomarkers Market, 2022 - 2028 (USD Million)
        • 7.7.5.1 The Middle-East and Africa Non-Alcoholic Steatohepatitis Biomarkers Market, by Country, 2022 - 2028 (USD Million)
    • 7.4 The Middle-East and Africa Non-Alcoholic Steatohepatitis Biomarkers Market, by Biomarker Type, 2022 - 2028
      • 7.4.1 The Middle-East and Africa Non-Alcoholic Steatohepatitis Biomarkers Market, by Biomarker Type, 2022 - 2028 (USD Million)
    • 7.5 The Middle-East and Africa Non-Alcoholic Steatohepatitis Biomarkers Market, by End-User, 2022 - 2028
      • 7.5.1 The Middle-East and Africa Non-Alcoholic Steatohepatitis Biomarkers Market, by End-User, 2022 - 2028 (USD Million)
  • Chapter 8. Company Profiles
    • 8.1 Biopredictive
      • 8.1.1 Overview
      • 8.1.2 Financials
      • 8.1.3 Product Portfolio
      • 8.1.4 Business Strategy
      • 8.1.5 Recent Developments
    • 8.2 Quest Diagnostics
      • 8.2.1 Overview
      • 8.2.2 Financials
      • 8.2.3 Product Portfolio
      • 8.2.4 Business Strategy
      • 8.2.5 Recent Developments
    • 8.3 Exalenz Bioscience Ltd
      • 8.3.1 Overview
      • 8.3.2 Financials
      • 8.3.3 Product Portfolio
      • 8.3.4 Business Strategy
      • 8.3.5 Recent Developments
    • 8.4 GENFIT
      • 8.4.1 Overview
      • 8.4.2 Financials
      • 8.4.3 Product Portfolio
      • 8.4.4 Business Strategy
      • 8.4.5 Recent Developments
    • 8.5 Siemens Healthineers
      • 8.5.1 Overview
      • 8.5.2 Financials
      • 8.5.3 Product Portfolio
      • 8.5.4 Business Strategy
      • 8.5.5 Recent Developments
    • 8.6 ONE WAY LIVER
      • 8.6.1 Overview
      • 8.6.2 Financials
      • 8.6.3 Product Portfolio
      • 8.6.4 Business Strategy
      • 8.6.5 Recent Developments
    • 8.7 S.L
      • 8.7.1 Overview
      • 8.7.2 Financials
      • 8.7.3 Product Portfolio
      • 8.7.4 Business Strategy
      • 8.7.5 Recent Developments
    • 8.8 Prometheus Laboratories Inc
      • 8.8.1 Overview
      • 8.8.2 Financials
      • 8.8.3 Product Portfolio
      • 8.8.4 Business Strategy
      • 8.8.5 Recent Developments
    • 8.9 Gilead Sciences Ltd.
      • 8.9.1 Overview
      • 8.9.2 Financials
      • 8.9.3 Product Portfolio
      • 8.9.4 Business Strategy
      • 8.9.5 Recent Developments

Table Of Figures

  • 1. Market research Type
  • 2. Market research methodology
  • 3. Global Non-Alcoholic Steatohepatitis Biomarkers Market, 2022 - 2028 (USD Million)
  • 4. Porter’s Five Forces Analysis
  • 5. Global Non-Alcoholic Steatohepatitis Biomarkers Market attractiveness, By Biomarker Type
  • 6. Global Non-Alcoholic Steatohepatitis Biomarkers Market attractiveness, By End-User
  • 7. Global Non-Alcoholic Steatohepatitis Biomarkers Market share by Biomarker Type, 2022 and 2028 (USD Million)
  • 8. Global Non-Alcoholic Steatohepatitis Biomarkers Market by Serum Biomarkers, 2022 - 2028 (USD Million)
  • 9. Global Non-Alcoholic Steatohepatitis Biomarkers Market by Biomarker Panels, 2022 - 2028 (USD Million)
  • 10. Global Non-Alcoholic Steatohepatitis Biomarkers Market by Fibrosis Biomarkers, 2022 - 2028 (USD Million)
  • 11. Global Non-Alcoholic Steatohepatitis Biomarkers Market by Imaging Biomarkers, 2022 - 2028 (USD Million)
  • 12. Global Non-Alcoholic Steatohepatitis Biomarkers Market by Others, 2022 - 2028 (USD Million)
  • 13. Global Non-Alcoholic Steatohepatitis Biomarkers Market share by End-User, 2022 and 2028 (USD Million)
  • 14. Global Non-Alcoholic Steatohepatitis Biomarkers Market by Hospitals, 2022 - 2028 (USD Million)
  • 15. Global Non-Alcoholic Steatohepatitis Biomarkers Market by Diagnostic Centers, 2022 - 2028 (USD Million)
  • 16. Global Non-Alcoholic Steatohepatitis Biomarkers Market by Others, 2022 - 2028 (USD Million)
  • 17. Global Non-Alcoholic Steatohepatitis Biomarkers Market share, by Region, 2022 and 2028
  • 18. North America Non-Alcoholic Steatohepatitis Biomarkers Market, 2022 - 2028 (USD Million)
  • 19. Europe Non-Alcoholic Steatohepatitis Biomarkers Market, 2022 - 2028 (USD Million)
  • 20. Asia Pacific Non-Alcoholic Steatohepatitis Biomarkers Market, 2022 - 2028 (USD Million)
  • 21. Latin America Non-Alcoholic Steatohepatitis Biomarkers Market, 2022 - 2028 (USD Million)
  • 22. The Middle-East and Africa Non-Alcoholic Steatohepatitis Biomarkers Market, 2022 - 2028 (USD Million)

Table Of Tables

  • 1. Global Non-Alcoholic Steatohepatitis Biomarkers Market: Snapshot
  • 2. Drivers of the Non-Alcoholic Steatohepatitis Biomarkers Market: impact analysis
  • 3. North America Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By Biomarker Type, 2022 - 2028 (USD Million)
  • 4. North America Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 5. U.S. Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By Biomarker Type, 2022 - 2028 (USD Million)
  • 6. U.S. Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 7. Canada Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By Biomarker Type, 2022 - 2028 (USD Million)
  • 8. Canada Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 9. Europe Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By Biomarker Type, 2022 - 2028 (USD Million)
  • 10. Europe Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 11. Germany Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By Biomarker Type, 2022 - 2028 (USD Million)
  • 12. Germany Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 13. France Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By Biomarker Type, 2022 - 2028 (USD Million)
  • 14. France Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 15. U.K. Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By Biomarker Type, 2022 - 2028 (USD Million)
  • 16. U.K. Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 17. Italy Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By Biomarker Type, 2022 - 2028 (USD Million)
  • 18. Italy Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 19. Spain Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By Biomarker Type, 2022 - 2028 (USD Million)
  • 20. Spain Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 21. Rest of Europe Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By Biomarker Type, 2022 - 2028 (USD Million)
  • 22. Rest of Europe Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 23. Asia Pacific Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By Biomarker Type, 2022 - 2028 (USD Million)
  • 24. Asia Pacific Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 25. China Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By Biomarker Type, 2022 - 2028 (USD Million)
  • 26. China Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 27. Japan Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By Biomarker Type, 2022 - 2028 (USD Million)
  • 28. Japan Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 29. India Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By Biomarker Type, 2022 - 2028 (USD Million)
  • 30. India Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 31. South Korea Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By Biomarker Type, 2022 - 2028 (USD Million)
  • 32. South Korea Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 33. South-East Asia Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By Biomarker Type, 2022 - 2028 (USD Million)
  • 34. South-East Asia Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 35. Rest of Asia Pacific Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By Biomarker Type, 2022 - 2028 (USD Million)
  • 36. Rest of Asia Pacific Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 37. Latin America Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By Biomarker Type, 2022 - 2028 (USD Million)
  • 38. Latin America Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 39. Brazil Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By Biomarker Type, 2022 - 2028 (USD Million)
  • 40. Brazil Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 41. Mexico Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By Biomarker Type, 2022 - 2028 (USD Million)
  • 42. Mexico Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 43. Rest of Latin America Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By Biomarker Type, 2022 - 2028 (USD Million)
  • 44. Rest of Latin America Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 45. The Middle-East and Africa Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By Biomarker Type, 2022 - 2028 (USD Million)
  • 46. The Middle-East and Africa Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 47. GCC Countries Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By Biomarker Type, 2022 - 2028 (USD Million)
  • 48. GCC Countries Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 49. South Africa Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By Biomarker Type, 2022 - 2028 (USD Million)
  • 50. South Africa Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 51. Rest of Middle-East Africa Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By Biomarker Type, 2022 - 2028 (USD Million)
  • 52. Rest of Middle-East Africa Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By End-User, 2022 - 2028 (USD Million)

Methodology

FrequentlyAsked Questions

In the next years, demand for noninvasive diagnostic techniques is likely to increase due to the rising prevalence of chronic liver disorders. Over the projection period, the demand for noninvasive diagnostic tools is likely to increase along with patient awareness levels, which is expected to support the development of non-alcoholic steatohepatitis biomarkers.

According to the report, the global non-alcoholic steatohepatitis biomarkers market size was worth USD 1,218.5 million in 2021 and is estimated to grow to USD 5,234.6 million by 2028, with a compound annual growth rate (CAGR) of approximately 27.5% over the forecast period.

The market for non-alcoholic steatohepatitis biomarkers is expanding in North America due to a number of causes, including supportive government policies, the increased incidence of infectious disorders, cardiovascular conditions, and diabetes.

Some of the main competitors dominating the global non-alcoholic steatohepatitis biomarkers market include- Biopredictive, Quest Diagnostics, Exalenz Bioscience Ltd, GENFIT, Siemens Healthineers, ONE WAY LIVER, S.L, Prometheus Laboratories Inc, and Gilead Sciences Ltd.

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

twitter

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed